Legacy continuity GenoFAB concluded operations in 2025 and GenoCAD maintains this page for professional continuity and archival reference, signaling potential interest from researchers who require legacy plasmid catalogs or historical project data.

Plug and play plasmids Strong opportunity for upsell to researchers needing rapid ship times and scalable TrueVectors, with a value proposition around ready-to-use plasmids and customization for gene of interest.

Premium services Existing offerings in premium design, synthesis, and purification services for non-standard plasmids present cross-sell opportunities to labs pursuing bespoke vectors and higher fidelity workflows.

Sequencing demand Recent GenoFAB plasmid sequencing service launch indicates a market need for quality control and reproducibility; potential expansion via bundled sequencing with plasmid purchases to attract bioresearch and biomanufacturing customers.

Sustainability angle Historical focus on remote 5S consulting and cloud-based workflows highlights a sustainability and efficiency narrative that can be translated into targeted offerings for labs aiming to improve culture, lean operations, and compliance in biomanufacturing.